ASEAN MedTech Insights cover art

ASEAN MedTech Insights

ASEAN MedTech Insights

By: Ran Chen
Listen for free

About this listen

Welcome to ASEAN MedTech Insights, the premier podcast dedicated to the thriving medical technology landscape of Southeast Asia. Each episode, we explore the cutting-edge innovations, investment trends, and regulatory developments in one of the world's fastest-growing markets. Join us for exclusive interviews with the founders, executives, and visionaries shaping the future of healthcare in the ASEAN region.Copyright 2025 Ran Chen
Episodes
  • Unlocking Vietnam's MedTech Market: A Pure Global Deep Dive on Critical Labeling and Language Regulations for ASEAN Success.
    Aug 26 2025
    This episode of ASEAN MedTech Insights tackles one of the most significant hurdles for medical technology companies entering Vietnam: the country's strict and specific labeling and language regulations. We demystify the requirements under key decrees like Decree 98/2021/ND-CP, providing a clear path to compliance for foreign manufacturers. We break down the practical solutions that successful companies use, focusing on the accepted practice of supplementary labeling. Learn what mandatory information must be translated into Vietnamese and how to manage the critical Instructions for Use (IFU) to avoid your products being held at customs. This is a must-listen for any regulatory affairs professional, exporter, or business leader looking to succeed in the vibrant Vietnamese market. A specific case: Imagine this. Your state-of-the-art medical device, fully compliant in Europe and the US, is stuck at a Vietnamese port. The shipment is delayed, storage costs are mounting, and your local partner is frustrated. The reason is a simple missing Vietnamese-language sticker and a non-translated user manual. This common, costly scenario is entirely avoidable, and we explain how. What you'll learn in this episode: 1. What is the single mandatory language for all medical device labels in Vietnam? 2. Can I use a sticker on my original packaging to meet local requirements, and what are the rules? 3. What specific information must be included on a compliant Vietnamese label? 4. Are English Instructions for Use (IFU) ever acceptable, or must they always be translated? 5. What is the most common labeling mistake that causes customs delays for MedTech companies in Vietnam? 6. How does Decree 98/2021/ND-CP fundamentally change the labeling strategy for market entry? 7. Who is legally responsible for ensuring the label is correct before the product reaches the end-user? 8. Are there any exceptions for electronic or online user manuals? Pure Global offers end-to-end regulatory consulting solutions for MedTech and IVD companies, combining local expertise with advanced AI and data tools to streamline global market access. We act as your local representative to ensure your market entry is smooth, compliant, and successful. To avoid common pitfalls and accelerate your growth in Vietnam and beyond, contact our experts at info@pureglobal.com or visit us at https://pureglobal.com/.
    Show More Show Less
    3 mins
  • Pure Global's Guide to Indonesian Market Access: Choosing Your Local Authorized Representative in the Heart of ASEAN
    Aug 25 2025
    Navigating the Indonesian MedTech market presents a critical challenge for foreign manufacturers: the mandatory appointment of a Local Authorized Representative (LAR). This isn't merely an administrative step; it's a strategic decision that defines who controls your product's registration license and, ultimately, your access to one of Southeast Asia's largest markets. This episode of ASEAN MedTech Insights explores the two primary options for an LAR—appointing your distributor versus partnering with an independent third party. We uncover the hidden risks of tying your regulatory license to a commercial partner and explain why an independent representative provides the flexibility and control necessary for long-term success and scalability in the complex Indonesian archipelago. For example, consider a European diagnostics firm that allowed its sole distributor in Indonesia to hold its product licenses. When a disagreement arose over sales performance, the firm decided to switch partners, only to find their licenses were held hostage by the original distributor. This forced them into a costly, two-year re-registration process, effectively locking them out of the market and forfeiting significant revenue. Key Takeaways: * Why is appointing a Local Authorized Representative a mandatory first step for selling medical devices in Indonesia? * What are the hidden risks of allowing your distributor to be your legal license holder? * How does the ownership of the registration license (Izin Edar) impact your ability to change commercial partners? * What happens to your market access if your relationship with a distributor-representative ends poorly? * Why is an independent representative model considered a safer, more flexible strategy for market entry? * How can you build a multi-distributor network in Indonesia without re-registering your product for each one? * What is the strategic difference between regulatory control and commercial strategy in the ASEAN context? At Pure Global, we provide MedTech and IVD companies with end-to-end regulatory solutions, including acting as your independent Local Authorized Representative in Indonesia and over 30 markets worldwide. Our combination of local expertise and advanced AI tools streamlines your global market access. To maintain full control of your assets and build a flexible market strategy, contact us at info@pureglobal.com or visit https://pureglobal.com/.
    Show More Show Less
    3 mins
  • Pure Global's ASEAN MedTech Insights: Leveraging Your CE Mark or FDA Approval for Expedited Medical Device Registration in Thailand
    Aug 24 2025
    In this episode of ASEAN MedTech Insights, we tackle a crucial question for global MedTech manufacturers: Can your existing CE mark or FDA approval fast-track your medical device registration in Thailand? We dive into the specifics of the Thai FDA's expedited pathways, explaining how you can leverage your prior approvals to gain a competitive edge in one of Southeast Asia's most dynamic markets. We explore the "Concise Evaluation Route," detailing which device classes are eligible and what the process actually entails. This is not a simple green light; it's a streamlined review that still demands meticulous preparation. A U.S. diagnostics company learned this the hard way. They assumed their FDA approval was a golden ticket into Thailand, only to face significant delays due to misunderstandings about local license holder requirements and the specific format needed for their technical documentation, costing them an estimated six months in lost revenue and market momentum. Key Takeaways: * What exactly is Thailand's "Concise Evaluation Route" and does my device qualify? * Is my FDA 510(k) or CE mark an automatic passport to the Thai market? * Beyond my approval certificate, what key documents does the Thai FDA still require? * Why is a local Thailand license holder mandatory even with an expedited application? * How can I format my existing technical files to meet the ASEAN CSDT standard? * What are the most common mistakes that lead to delays, even on an expedited pathway? * Are there language requirements for labeling and instructions that I need to know? * How does the expedited process in Thailand compare to other ASEAN countries like Malaysia or Vietnam? Struggling to turn your global approvals into rapid ASEAN market access? Pure Global offers end-to-end regulatory consulting, combining local expertise with advanced AI to streamline your entry into over 30 global markets. We act as your local representative and ensure your submission is right the first time. Contact us at info@pureglobal.com or visit https://pureglobal.com/ to learn more.
    Show More Show Less
    2 mins
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.